The first analyses of data from the Phase 2b vaccine trial A-055 show that the tuberculosis (TB) vaccine candidate, H56:IC31, was well tolerated and demonstrated an immune response…

The National Institute for Medical Research (NIMR) Tanzania leadership is thrilled to announce a multi-million-dollar research award to advance HIV vaccine innovation within the African continent.…

Brilliant Consortium has appointed Dr Nyanda Elias Ntinginya to serve as a member in the Executive Committee in addition to his role as the Lead in…

on 18th December 2023 NIMR conducted a manuscript writing training to early and mid-career research scientists in order to impart knowledge and skills and in efforts…

On 12th December 2023 NIMR conducted a training which aimed at facilitating accreditation of short course curricula prepared by the research scientists. Gracing the event, Director…

In recent weeks, the residents of Hanang district have faced the devastating impact of floods triggered by incessant rainfall. As the rain continues to pour across…

The National Institute for Medical Research (NIMR) conducted on 28th November 2023, a training workshop for research stakeholders to orient them on newly developed guidelines on…

In a momentous occasion, the National Institute for Medical Research (NIMR) received the Acknowledgment Award from the Vanke School of Public Health at Tsinghua University in…

In a proactive move towards advancing the ethical standards of medical research in Tanzania, the National Institute for Medical Research (NIMR) conducted a comprehensive training workshop…